CD274 and neoplasm: The nanoparticles were Isorhamnetin (ISO) and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles (HMSN-ISO@ProAPD-L1 Ab), which were prepared as an anti-tumor drug to play a synergistic anti-tumor role.